Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
06/1995
06/28/1995EP0659768A2 Antigen-carbohydrate conjugates and their use in immunotherapy
06/28/1995EP0659767A1 Process to prepare an anti-D immunoglobulin G concentrate and pharmaceutical compositions comprising it
06/28/1995EP0659765A2 Immunoreactive peptides of apo(a)
06/28/1995EP0659439A2 Immunoconjugates
06/28/1995EP0659276A1 Immunoassay for detecting collagen or collagen fragments
06/28/1995EP0659214A1 Allergenic proteins and peptides from japanese cedar pollen
06/28/1995EP0659212A1 Mammamodulin, a hormone-independent mammary tumor cells specific protein
06/28/1995EP0659209A1 Cancer therapy utilizing malignant cells
06/28/1995EP0659192A1 Novel antibodies for conferring passive immunity against infection by a pathogen in humans
06/28/1995EP0659086A1 Novel bacterial vaccines using vaccine strains of pathogenic bacteria
06/28/1995EP0539405B1 Peptides and analogues and mixtures thereof for detecting antibodies to htlv-i and htlv-ii viruses
06/28/1995EP0521897B1 Idiotypic vaccination against b cell lymphoma
06/28/1995EP0465556B1 Platelet specific immunoconjugates
06/28/1995EP0460171B1 Cd3 specific recombinant antibody
06/28/1995EP0439540B1 Antibody conjugates with two or more covalently linked fc regions
06/28/1995EP0432220B1 Vaccines and diagnostic assays for haemophilus influenzae
06/28/1995CN1104216A Artifical antigen preparation-hapten and protein cross-link method
06/27/1995US5428145 Isolated RNA
06/27/1995US5428134 Antibody reagents that specifically bind to the carboxyl-terminal decaptide of specific GTP-binding proteins
06/27/1995US5428133 Chimeric anti-human IgE-monoclonal antibody which binds to secreted IgE and membrane-bound IgE expressed by IgE-expressing B cells but notto IgE bound to FC receptors on basophils
06/27/1995US5428023 Oral delivery of biologically active substances bound to vitamin B12 or analogues thereof
06/27/1995US5427958 Detecting presence of autoantibodies in biological fluids; forming peptide complexes; in vitro; diagnosing lupus, autoimmune diseases
06/27/1995US5427954 Detection of aggrecan by-products
06/27/1995US5427939 Expression vectors encoding alloantigens of glycoprotein Ibα
06/27/1995US5427937 Hookworm anticoagulant
06/27/1995US5427792 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus
06/27/1995US5427791 Embryonal vaccine against Newcastle disease
06/27/1995US5427788 Pertussis toxin and use in vaccines
06/27/1995US5427782 Administering complexes of viral envelope glycoproteins and lipids
06/27/1995CA1336119C Vinca derivative conjugates containing a c-3 detergent chain
06/27/1995CA1336076C Metal radionuclide labeled proteins for diagnosis and therapy
06/23/1995CA2138178A1 Control of ph during bordetella growth
06/22/1995WO1995016915A1 METHODS AND MATERIALS FOR THE DETECTION OF $i(STAPHYLOCOCCUS AUREUS)
06/22/1995WO1995016894A1 Maleimide adduct conjugates of procainamide and napa
06/22/1995WO1995016779A1 Herpes-symplex-virus type 2 icp4 protein and its use in a vaccine composition
06/22/1995WO1995016775A1 Tumor cell fusions and methods for use of such tumor cell fusions
06/22/1995WO1995016711A1 Antibodies against pneumolysine and their applications
06/22/1995WO1995016710A1 Specific hyperimmune anti-hiv globulin for passive immunization
06/22/1995WO1995016464A1 Controlled release of pharmaceutically active substances for immunotherapy
06/22/1995WO1995016461A1 PROBIOTIC FOR CONTROL OF $i(SALMONELLA)
06/22/1995WO1995016453A1 A medicament, pack containing a medicament, and a method of administering a medicament
06/22/1995WO1995016452A2 Use of macrophage depleting agents for prolonging the survival of non-autologus hematopoietic cell transplants and animal model assay systems
06/22/1995WO1995016437A1 Method of transmitting a biologically active material to a cell
06/22/1995WO1995015381A3 Human mutator gene hmsh2 and hereditary non polyposis colorectal cancer
06/22/1995WO1995014781A3 Methods for diagnosing early lyme disease
06/22/1995WO1995009241A3 Anti-cancer gene therapy by modulation of immune or inflammatory response
06/22/1995WO1995007992A3 Cloned glutamic acid decarboxylase
06/22/1995WO1995007987A3 Novel proteins/polypeptides and cotransfection plasmids and live recombinant carriers therefor
06/22/1995DE4419264A1 Antigen, um Menschen und Tieren eine schützende Immunität gegen Wurminfektionen zu verleihen To confer antigen humans and animals protective immunity against worm infections
06/22/1995CA2179149A1 Methods and materials for the detection of staphylococcus aureus
06/22/1995CA2178950A1 Tumor cell fusions and methods for use of such tumor cell fusions
06/22/1995CA2178902A1 Controlled release of pharmaceutically active substances for immunotherapy
06/22/1995CA2178192A1 Probiotic for control of salmonella
06/22/1995CA2174729A1 A method of preventing depletion of non-autologous hematopoietic cells and animal model systems for use thereof
06/22/1995CA2138605A1 Immunoreactive peptides of apo(a)
06/21/1995EP0658623A2 Attenuated herpesviruses, herpesviruses which include foreign DNA encoding an amino acid sequence and vaccines containing same
06/21/1995EP0658205A1 Lipoprotein associated phospholipase a 2?, inhibitors thereof and use of the same in diagnosis and therapy
06/21/1995EP0658168A1 Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein
06/21/1995EP0658120A1 Conjugates of poorly immunogenic antigens and synthetic peptide carriers and vaccines comprising them
06/21/1995EP0658119A1 New hiv-1 isolates of a subtype and its differential diagnosis, vaccine against hiv-1 infection of this subtype and process for preparing and using the hiv-1 isolate
06/21/1995EP0658118A1 Vaccines against group c neisseria meningitidis
06/21/1995EP0658115A1 Peptide medicaments for treating disease
06/21/1995EP0658113A1 Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof
06/21/1995EP0658111A1 Methods for enhancing drug delivery with modified saponins
06/21/1995EP0540588B1 A composition providing improved clearance of bioactive substances from the bloodstream
06/20/1995US5426181 DNA encoding cytokine-induced protein, TSG-14
06/20/1995US5426051 Plasmid containing gene and expression control region for the gene, for homologous recombination with vaccinia virus
06/20/1995US5426044 Minactivin compositions and antibodies to minactivin
06/20/1995US5425946 Administering vaccine comprising injectable excipient and carrier covalently coupled to o-deacetylated group c meningococcal polysaccharide
06/20/1995CA1335959C Newcastle disease virus vaccine and method for the application thereof
06/16/1995CA2137640A1 Anti-idiotypic antibody having correspondence with human hepatitis b surface antigen
06/15/1995WO1995016045A1 Construction of pasteurella heamolytica vaccines
06/15/1995WO1995016038A2 Humanized antibodies and uses thereof
06/15/1995WO1995016033A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY
06/15/1995WO1995015979A1 Pretargeting methods and compounds
06/15/1995WO1995015978A1 Pretargeting methods and compounds
06/15/1995WO1995015977A1 Peptide representing antigenic epitopes of feline ige present on feline b-cells but not feline basophil cell surfaces
06/15/1995WO1995015976A1 Nucleic acids encoding a house dust mite allergen, der p iii, and uses therefor
06/15/1995WO1995015769A1 Preparation and use of immunoconjugates
06/15/1995WO1995015768A1 Adjuvant for antigens, process for producing the same and its use
06/15/1995WO1995015764A1 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope
06/15/1995WO1995013297A3 Improved immunogenic compositions against human gastrin 17
06/15/1995CA2178622A1 Humanized antibodies and uses thereof
06/15/1995CA2178477A1 Pretargeting methods and compounds
06/15/1995CA2178476A1 Pretargeting methods and compounds
06/15/1995CA2177464A1 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope
06/15/1995CA2176825A1 C5a receptor antagonists having substantially no agonist activity
06/14/1995EP0657536A1 Proteases capable of shedding the soluble TNF-receptor and TNF-R derived peptides and antibodies against the proteases inhibiting the shedding
06/14/1995EP0657533A1 Monoclonal antibodies with high cytotoxicity against the human CD16 antigen, and bispecific monoclonal antibodies using such monoclonal antibodies and the CD30-HRS-3 antibody
06/14/1995EP0657532A1 HIV-3 retrovirus strains and their use
06/14/1995EP0657471A1 Anti ganglioside monoclonal antibodies and their use in the specific active immunotherapy of malignant tumours
06/14/1995EP0657468A1 Human stromae derived factor
06/14/1995EP0657175A2 Vaccine comprising autologous epidermal growth factor and use thereof
06/14/1995EP0656950A1 Tat-derived transport polypeptides
06/14/1995EP0656948A1 $i(BORDETELLA BRONCHISEPTICA) VACCINE
06/14/1995EP0656947A1 Human interleukin-13
06/14/1995EP0656946A1 Immunoglobulins devoid of light chains
06/14/1995EP0656945A1 Stress protein epitopes
06/14/1995EP0656906A1 A novel endothelial cell molecule mediating lymphocyte binding in man
06/14/1995EP0656789A1 Method for treating a lfa-1-mediated disorder
1 ... 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 1676 1677 1678 1679 1680 1681 1682 1683 1684 ... 1823